Proteomics and the search for biomarkers of female reproductive diseases

Reproduction : the Official Journal of the Society for the Study of Fertility
K L MeehanAndrew N Stephens

Abstract

Over the past decade, high-throughput proteomics technologies have evolved considerably and have become increasingly more commonly applied to the investigation of female reproductive diseases. Proteomic approaches facilitate the identification of new disease biomarkers by comparing the abundance of hundreds of proteins simultaneously to find those specific to a particular clinical condition. Some of the best studied areas of female reproductive biology applying proteomics include gynaecological cancers, endometriosis and endometrial infertility. This review will discuss the progress that has been made in these areas and will highlight some of the emerging technologies that promise to contribute to better understanding of the female reproductive disease.

References

Jul 15, 1999·Nature Biotechnology·A J LinkJ R Yates
Sep 15, 2000·Journal of Immunological Methods·D A Vignali
Apr 2, 2002·Biochemical and Biophysical Research Communications·Haleem J IssaqDonna Felschow
Apr 3, 2002·JAMA : the Journal of the American Medical Association·Jae-Hoon KimSamuel C Mok
Jun 17, 2004·British Journal of Cancer·K HellmanG Auer
Oct 7, 2004·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·Linda C Giudice
Dec 17, 2004·Proteomics·Alexander SchmidtFriedrich Lottspeich
Jun 22, 2005·Expert Review of Proteomics·Edgar NägeleCornelia Vad
Jun 22, 2005·Expert Review of Proteomics·Mark Brönstrup
Oct 6, 2005·American Journal of Obstetrics and Gynecology·Vivian E von GruenigenMichael P Hopkins
Oct 21, 2005·Proteomics·Katherine R KozakRobin Farias-Eisner
Feb 2, 2006·Analytical Chemistry·Hans-Rudolf AerniRichard M Caprioli
Mar 15, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carla A BorgoñoEleftherios P Diamandis
Apr 8, 2006·Trends in Pharmacological Sciences·Judith Y M N EngwegenJos H Beijnen
Apr 28, 2006·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Anna P PonnampalamPeter A W Rogers
Jun 29, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Y-W LinT-Y Chu
Jul 26, 2006·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Liu-Ying LuoEleftherios P Diamandis
Aug 8, 2006·Journal of Proteome Research·Vitor FacaSamir Hanash
Aug 19, 2006·Clinical Chemistry·Shannon J C ShanEleftherios P Diamandis
Sep 2, 2006·Obstetrics and Gynecology·John K ChanKathryn Osann
Sep 9, 2006·Human Reproduction Update·J A HorcajadasC Simón
Sep 23, 2006·Proteomics·Ingrid MillerElisabetta Gianazza
Feb 17, 2007·Gynecologic Oncology·Ie-Ming ShihEleftherios P Diamandis
Feb 24, 2007·Journal of Proteome Research·Sofia BengtssonPeter James
Feb 27, 2007·Cancer Letters·David M RobertsonTom Jobling
Mar 7, 2007·Journal of Proteome Research·Laura González-SantiagoJ Ignacio Casal

❮ Previous
Next ❯

Citations

Mar 4, 2011·Reproduction, Fertility, and Development·Csaba Pribenszky, Gabor Vajta
Aug 30, 2011·Reproduction, Fertility, and Development·Dorit Kalo, Zvi Roth
May 1, 2012·Reproduction, Fertility, and Development·Mohammad Bozlur RahmanAnn Van Soom
Oct 2, 2013·Human Reproduction Update·Signe AltmäeAndres Salumets
Jun 6, 2014·BioMed Research International·Sajal GuptaAshok Agarwal
Oct 10, 2012·Fertility and Sterility·Lois A SalamonsenNatalie J Hannan
Nov 7, 2015·Proteomics. Clinical Applications·Parul MittalPeter Hoffmann
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Lorena Alonso-AlconadaMiguel Abal
Jul 31, 2013·Proteomics. Clinical Applications·A B SivaSisinthy Shivaji
Aug 12, 2014·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Rosa Anna SicilianoNadia Miraglia
Mar 22, 2014·Expert Review of Molecular Diagnostics·Tea Lanišnik Rižner, Tea Lanišnik Rižner
Oct 3, 2018·Journal of Ovarian Research·Agata SwiatlyZenon J Kokot
Mar 4, 2021·Reproductive Biology and Endocrinology : RB&E·Yingxian JiaJianhong Zhou
Jun 11, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Paulina BanachEwa Nowak-Markwitz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.